Clinical Trial Update: Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating macrolide antibiotics to prevent exacerbations in asthma and chronic obstructive pulmonary disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Macrolide antibiotics

Snippet

Sponsor: Johns Hopkins University | Conditions: Asthma, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: TERMINATED